Lifemd (LFMD) closed at $2.20 on November 13, 2026, up 32.6% from the previous close, on volume of 6,022,168 shares (30-day average 835,949).
Data as of November 13, 2026.
13-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 12, 2026. See the 10 largest for 30, 60 and 90 days
LifeMD GAAP EPS of -$0.11 beats by $0.03, revenue of $44.6M misses by $4.25M
Seeking Alpha News (Thu, 12-Nov 11:54 PM ET)
LifeMD Reports Third-Quarter Results and Subscriber Growth
TipRanks (Thu, 12-Nov 4:43 PM ET)
LifeMD Reports Third Quarter 2026 Results
Globe Newswire (Thu, 12-Nov 4:05 PM ET)
Business Wire (Tue, 10-Nov 11:00 AM ET)
Business Wire (Tue, 10-Nov 9:00 AM ET)
Business Wire (Mon, 9-Nov 2:55 PM ET)
LifeMD Delays Quarterly Report Amid Accounting Corrections
TipRanks (Mon, 9-Nov 9:15 AM ET)
LifeMD Reschedules Third Quarter 2026 Earnings Release and Conference Call to November 12, 2026
Globe Newswire (Fri, 6-Nov 7:25 PM ET)
Globe Newswire (Thu, 5-Nov 7:30 AM ET)
LifeMD to Report Third Quarter 2026 Financial Results on November 9
Globe Newswire (Tue, 20-Oct 4:05 PM ET)
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.
Lifemd trades on the NASDAQ stock market under the symbol LFMD.
As of November 13, 2026, LFMD stock price climbed to $2.19 with 6,022,168 million shares trading.
LFMD has a beta of 1.23, meaning it tends to be more sensitive to market movements. LFMD has a correlation of 0.05 to the broad based SPY ETF.
LFMD has a market cap of $105.92 million. This is considered a Micro Cap stock.
Last quarter Lifemd reported $45 million in Revenue and -$.11 earnings per share. This fell short of revenue expectation by $-4 million and missed earnings estimates by -$.08.
In the last 3 years, LFMD traded as high as $15.84 and as low as $1.60.
The top ETF exchange traded funds that LFMD belongs to (by Net Assets): VTI, IWM, VXF, KOMP, VTWO.
LFMD has underperformed the market in the last year with a price return of -56.7% while the SPY ETF gained +11.5%. LFMD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -33.3% and -5.4%, respectively, while the SPY returned -2.1% and -1.9%, respectively.
LFMD support price is $1.56 and resistance is $1.75 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LFMD shares will trade within this expected range on the day.
